Emerging avenues linking inflammation and cancer

Free Radical Biology and Medicine

Volumn 52, Issue 9, 2012, Pages 2013-2037

  Kundu, Joydeb Kumar ^a   Surh, Young Joon ^b,c  

^a Keimyung University   (South Korea)

^b Seoul National University   (South Korea)

^c WCU Department of Molecular Medicine and Biopharmaceutical Sciences   (South Korea)

Author keywords

Cancer; Cytokines; DNA damage; EMT; Epigenetics; Free radicals; Inflammation; miRNA

Indexed keywords

3 METHYLADENINE DEOXYRIBONUCLEIC ACID GLYCOSYLASE; ACTIVATION INDUCED CYTIDINE DEAMINASE; ALKYLADENINE DNA GLYCOSYLASE; APURINIC APYRIMIDINIC ENDONUCLEASE 1; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; DNA GLYCOSYLTRANSFERASE; ENDONUCLEASE; GALECTIN; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MICRORNA; MUCIN; MYELOPEROXIDASE; NEI LIKE DNA GLYCOSYLASE 1; NITRIC OXIDE; OSTEOPONTIN; PROSTAGLANDIN; PROTEIN MLH1; PROTEIN S 100; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; CANCER GROWTH; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHRONIC INFLAMMATION; COLON POLYPOSIS; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EXCISION REPAIR; GASTRITIS; GENOMIC INSTABILITY; HASHIMOTO DISEASE; HELICOBACTER INFECTION; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY LOSS; HUMAN; INFLAMMATION; LIVER CARCINOGENESIS; LUNG CARCINOGENESIS; LYMPHOCYTIC THYROIDITIS; MESOTHELIOMA; METASTATIC MELANOMA; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NEUROBLASTOMA; NEUROCYSTICERCOSIS; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; PROTEIN EXPRESSION; REVIEW; STOMACH CARCINOGENESIS; TELOMERE SHORTENING; THYROID PAPILLARY CARCINOMA; ULCERATIVE COLITIS;

ANIMALS; HUMANS; INFLAMMATION; NEOPLASMS;

EID: 84859635458     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.02.035     Document Type: Review

References (362)

1. B.B. Aggarwal, S. Shishodia, S.K. Sandur, M.K. Pandey, and G. Sethi Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72 2006 1605 1621
2. F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217
3. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
4. S.H. Itzkowitz, and X. Yio Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G7 G17
5. J.K. Kundu, and Y.J. Surh Inflammation: gearing the journey to cancer Mutat. Res. 659 2008 15 30
6. K.J. O'Byrne, and A.G. Dalgleish Chronic immune activation and inflammation as the cause of malignancy Br. J. Cancer 85 2001 473 483
7. H. Clevers At the crossroads of inflammation and cancer Cell 118 2004 671 674
8. P. Prior, S.N. Gyde, J.C. Macartney, H. Thompson, J.A. Waterhouse, and R.N. Allan Cancer morbidity in ulcerative colitis Gut 23 1982 490 497
9. J. Eaden, K. Abrams, A. Ekbom, E. Jackson, and J. Mayberry Colorectal cancer prevention in ulcerative colitis: a case-control study Aliment. Pharmacol. Ther. 14 2000 145 153
10. S.P. Hussain, and C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int. J. Cancer 121 2007 2373 2380
11. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 2009 1073 1081
12. C. Porta, P. Larghi, M. Rimoldi, M.G. Totaro, P. Allavena, A. Mantovani, and A. Sica Cellular and molecular pathways linking inflammation and cancer Immunobiology 214 2009 761 777
13. S. Mardente, A. Zicari, F. Consorti, E. Mari, M. Di Vito, M. Leopizzi, C. Della Rocca, and A. Antonaci Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer Oncol. Rep. 24 2010 1455 1461
14. J.S. Pufnock, and J.L. Rothstein Oncoprotein signaling mediates tumor-specific inflammation and enhances tumor progression J. Immunol. 182 2009 5498 5506
15. M.G. Borrello, L. Alberti, A. Fischer, D. Degl'innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, S. Pilotti, G. Cassinelli, P. Bressan, L. Fugazzola, A. Mantovani, and M.A. Pierotti Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene Proc. Natl. Acad. Sci. U. S. A. 102 2005 14825 14830
16. J.M. Hillegass, A. Shukla, S.A. Lathrop, M.B. MacPherson, S.L. Beuschel, K.J. Butnor, J.R. Testa, H.I. Pass, M. Carbone, C. Steele, and B.T. Mossman Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model Ann. N. Y. Acad. Sci. 1203 2010 7 14
17. M. Khalili, L.N. Mutton, B. Gurel, J.L. Hicks, A.M. De Marzo, and C.J. Bieberich Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia Am. J. Pathol. 176 2010 2259 2268
18. K. Iwanaga, Y. Yang, M.G. Raso, L. Ma, A.E. Hanna, N. Thilaganathan, S. Moghaddam, C.M. Evans, H. Li, W.W. Cai, M. Sato, J.D. Minna, H. Wu, C.J. Creighton, F.J. Demayo, I.I. Wistuba, and J.M. Kurie Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer Cancer Res. 68 2008 1119 1127
19. M.S. Cooke, M.D. Evans, M. Dizdaroglu, and J. Lunec Oxidative DNA damage: mechanisms, mutation, and disease FASEB J. 17 2003 1195 1214
20. L.J. Marnett Oxyradicals and DNA damage Carcinogenesis 21 2000 361 370
21. G.M. Halliday Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis Mutat. Res. 571 2005 107 120
22. A. Sarasin The molecular pathways of ultraviolet-induced carcinogenesis Mutat. Res. 428 1999 5 10
23. T.M. Covey, K. Edes, G.S. Coombs, D.M. Virshup, and F.A. Fitzpatrick Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer PLoS One 5 2010 e13545
24. T.M. Wagner, J.E. Mullally, and F.A. Fitzpatrick Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation J. Biol. Chem. 281 2006 2598 2604
25. B.W. Meier, J.D. Gomez, O.V. Kirichenko, and J.A. Thompson Mechanistic basis for inflammation and tumor promotion in lungs of 2,6-di-tert-butyl-4- methylphenol-treated mice: electrophilic metabolites alkylate and inactivate antioxidant enzymes Chem. Res. Toxicol. 20 2007 199 207
26. H. Sugiura, and M. Ichinose Nitrative stress in inflammatory lung diseases Nitric Oxide 25 2011 138 144
27. K.V. Ramana, A. Bhatnagar, S. Srivastava, U.C. Yadav, S. Awasthi, Y.C. Awasthi, and S.K. Srivastava Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth J. Biol. Chem. 281 2006 17652 17660
28. R. Tammali, S.K. Srivastava, and K.V. Ramana Targeting aldose reductase for the treatment of cancer Curr. Cancer Drug Targets 11 2011 560 571
29. T.M. Ravindranath, P.Y. Mong, R. Ananthakrishnan, Q. Li, N. Quadri, A.M. Schmidt, R. Ramasamy, and Q. Wang Novel role for aldose reductase in mediating acute inflammatory responses in the lung J. Immunol. 183 2009 8128 8137
30. R. Tammali, K.V. Ramana, S.S. Singhal, S. Awasthi, and S.K. Srivastava Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells Cancer Res. 66 2006 9705 9713
31. R. Tammali, K.V. Ramana, and S.K. Srivastava Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cells Cancer Lett. 252 2007 299 306
32. N. Babbar, T. Murray-Stewart, and R.A. Casero Jr. Inflammation and polyamine catabolism: the good, the bad and the ugly Biochem. Soc. Trans. 35 2007 300 304
33. A.P. Gobert, Y. Cheng, J.Y. Wang, J.L. Boucher, R.K. Iyer, S.D. Cederbaum, R.A. Casero Jr., J.C. Newton, and K.T. Wilson Helicobacter pylori induces macrophage apoptosis by activation of arginase II J. Immunol. 168 2002 4692 4700
34. R.A. Koza, L.C. Megosh, M. Palmieri, and T.G. O'Brien Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas Carcinogenesis 12 1991 1619 1625
35. F.L. Meyskens Jr., C.E. McLaren, D. Pelot, S. Fujikawa-Brooks, P.M. Carpenter, E. Hawk, G. Kelloff, M.J. Lawson, J. Kidao, J. McCracken, C.G. Albers, D.J. Ahnen, D.K. Turgeon, S. Goldschmid, P. Lance, C.H. Hagedorn, D.L. Gillen, and E.W. Gerner Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial Cancer Prev. Res. (Philadelphia) 1 2008 32 38
36. J.C. ter Steege, P.P. Forget, and W.A. Buurman Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model Shock 11 1999 115 119
37. G.P. Zagaja, M. Shrivastav, M.J. Fleig, L.J. Marton, C.W. Rinker-Schaeffer, and M.E. Dolan Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo Cancer Chemother. Pharmacol. 41 1998 505 512
38. L. Alhonen, J.J. Parkkinen, T. Keinanen, R. Sinervirta, K.H. Herzig, and J. Janne Activation of polyamine catabolism in transgenic rats induces acute pancreatitis Proc. Natl. Acad. Sci. U. S. A. 97 2000 8290 8295
39. T.L. Rasanen, L. Alhonen, R. Sinervirta, T. Keinanen, K.H. Herzig, S. Suppola, A.R. Khomutov, J. Vepsalainen, and J. Janne A polyamine analogue prevents acute pancreatitis and restores early liver regeneration in transgenic rats with activated polyamine catabolism J. Biol. Chem. 277 2002 39867 39872
40. H. Xu, R. Chaturvedi, Y. Cheng, F.I. Bussiere, M. Asim, M.D. Yao, D. Potosky, S.J. Meltzer, J.G. Rhee, S.S. Kim, S.F. Moss, A. Hacker, Y. Wang, R.A. Casero Jr., and K.T. Wilson Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis Cancer Res. 64 2004 8521 8525
41. M. Jaiswal, N.F. LaRusso, L.J. Burgart, and G.J. Gores Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism Cancer Res. 60 2000 184 190
42. H. Ohshima, T. Sawa, and T. Akaike 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis Antioxid. Redox Signal. 8 2006 1033 1045
43. V. Yermilov, J. Rubio, M. Becchi, M.D. Friesen, B. Pignatelli, and H. Ohshima Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro Carcinogenesis 16 1995 2045 2050
44. S. Kawanishi, and Y. Hiraku Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation Antioxid. Redox Signal. 8 2006 1047 1058
45. N.N. Tam, I. Leav, and S.M. Ho Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat Am. J. Pathol. 171 2007 1334 1341
46. H. Bartsch, and J. Nair Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies Mutat. Res. 591 2005 34 44
47. J. Nair, F. Gansauge, H. Beger, P. Dolara, G. Winde, and H. Bartsch Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis Antioxid. Redox Signal. 8 2006 1003 1010
48. Y. Yang, J. Fruehauf, S. Xiang, and C.J. Li Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients Cell Cycle 5 2006 1443 1447
49. W.S. Park, T. Pham, C. Wang, S. Pack, E. Mueller, J. Mueller, A. Vortmeyer, Z. Zhuang, and F. Fogt Loss of heterozygosity and microsatellite instability in non-neoplastic mucosa from patients with chronic ulcerative colitis Int. J. Mol. Med. 2 1998 221 224
50. T.A. Brentnall, D.A. Crispin, M.P. Bronner, S.P. Cherian, M. Hueffed, P.S. Rabinovitch, C.E. Rubin, R.C. Haggitt, and C.R. Boland Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis Cancer Res. 56 1996 1237 1240
51. T.A. Brentnall, R. Chen, J.G. Lee, M.B. Kimmey, M.P. Bronner, R.C. Haggitt, K.V. Kowdley, L.M. Hecker, and D.R. Byrd Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis Cancer Res. 55 1995 4264 4267
52. A.H. Moskovitz, N.J. Linford, T.A. Brentnall, M.P. Bronner, B.E. Storer, J.D. Potter, R.H. Bell Jr., and P.S. Rabinovitch Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma Genes Chromosomes Cancer 37 2003 201 206
53. L.A. Herrera, U. Rodriguez, E. Gebhart, and P. Ostrosky-Wegman Increased translocation frequency of chromosomes 7, 11 and 14 in lymphocytes from patients with neurocysticercosis Mutagenesis 16 2001 495 497
54. K. Werling, A. Szepesi, Z. Szentirmay, Z. Schaff, Z. Tulassay, and F. Szalay Effect of hepatitis C virus on hepatocyte proliferation and DNA ploidy in patients with chronic hepatitis C Z. Gastroenterol. 38 2000 553 554 556-558
55. Y. Endo, H. Marusawa, and T. Chiba Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers J. Gastroenterol. 46 Suppl. 1 2011 6 10
56. Y. Matsumoto, H. Marusawa, K. Kinoshita, Y. Endo, T. Kou, T. Morisawa, T. Azuma, I.M. Okazaki, T. Honjo, and T. Chiba Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium Nat. Med. 13 2007 470 476
57. S. Takaishi, and T.C. Wang Providing AID to p53 mutagenesis Nat. Med. 13 2007 404 406
58. T. Kou, H. Marusawa, K. Kinoshita, Y. Endo, I.M. Okazaki, Y. Ueda, Y. Kodama, H. Haga, I. Ikai, and T. Chiba Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis Int. J. Cancer 120 2007 469 476
59. O. Isokawa, T. Suda, Y. Aoyagi, H. Kawai, T. Yokota, T. Takahashi, K. Tsukada, T. Shimizu, S. Mori, Y. Abe, Y. Suzuki, M. Nomoto, Y. Mita, M. Yanagi, H. Igarashi, and H. Asakura Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis Hepatology 30 1999 408 412
60. L. Hou, S.A. Savage, M.J. Blaser, G. Perez-Perez, M. Hoxha, L. Dioni, V. Pegoraro, L.M. Dong, W. Zatonski, J. Lissowska, W.H. Chow, and A. Baccarelli Telomere length in peripheral leukocyte DNA and gastric cancer risk Cancer Epidemiol. Biomarkers Prev. 18 2009 3103 3109
61. H. Kuniyasu, Y. Kitadai, H. Mieno, and W. Yasui Helicobactor pylori infection is closely associated with telomere reduction in gastric mucosa Oncology 65 2003 275 282
62. Mu, Y.; Zhang, Q.; Mei, L.; Liu, X.; Yang, W.; Yu, J. Telomere shortening occurs early during gastrocarcinogenesis. Med. Oncol. doi: 10.1007/s12032-011- 9866-3 Electronic publication ahead of print published online February 2011.
63. R.A. Risques, L.A. Lai, C. Himmetoglu, A. Ebaee, L. Li, Z. Feng, M.P. Bronner, B. Al-Lahham, K.V. Kowdley, K.D. Lindor, P.S. Rabinovitch, and T.A. Brentnall Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation Cancer Res. 71 2011 1669 1679
64. L.B. Meira, J.M. Bugni, S.L. Green, C.W. Lee, B. Pang, D. Borenshtein, B.H. Rickman, A.B. Rogers, C.A. Moroski-Erkul, J.L. McFaline, D.B. Schauer, P.C. Dedon, J.G. Fox, and L.D. Samson DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice J. Clin. Invest. 118 2008 2516 2525
65. Z. Feng, W. Hu, and M.S. Tang Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis Proc. Natl. Acad. Sci. U. S. A. 101 2004 8598 8602
66. N. Gungor, R.W. Godschalk, D.M. Pachen, F.J. Van Schooten, and A.M. Knaapen Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase FASEB J. 21 2007 2359 2367
67. N. Gungor, A. Haegens, A.M. Knaapen, R.W. Godschalk, R.K. Chiu, E.F. Wouters, and F.J. van Schooten Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo Mutagenesis 25 2010 77 82
68. S. Acharya, T. Wilson, S. Gradia, M.F. Kane, S. Guerrette, G.T. Marsischky, R. Kolodner, and R. Fishel hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6 Proc. Natl. Acad. Sci. U. S. A. 93 1996 13629 13634
69. M. Raschle, G. Marra, M. Nystrom-Lahti, P. Schar, and J. Jiricny Identification of hMutLβ, a heterodimer of hMLH1 and hPMS1 J. Biol. Chem. 274 1999 32368 32375
70. C.L. Chang, G. Marra, D.P. Chauhan, H.T. Ha, D.K. Chang, L. Ricciardiello, A. Randolph, J.M. Carethers, and C.R. Boland Oxidative stress inactivates the human DNA mismatch repair system Am. J. Physiol. Cell Physiol. 283 2002 C148 C154
71. C. Campregher, M.G. Luciani, and C. Gasche Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells Gut 57 2008 780 787
72. M.R. Kohonen-Corish, J.J. Daniel, H. te Riele, G.D. Buffinton, and J.E. Dahlstrom Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors Cancer Res. 62 2002 2092 2097
73. K. Taniguchi, S. Kakinuma, Y. Tokairin, M. Arai, H. Kohno, K. Wakabayashi, T. Imaoka, E. Ito, M. Koike, H. Uetake, M. Nishimura, K. Yamauchi, K. Sugihara, and Y. Shimada Mild inflammation accelerates colon carcinogenesis in Mlh1-deficient mice Oncology 71 2006 124 130
74. W. Bartchewsky Jr., M.R. Martini, A.C. Squassoni, M.C. Alvarez, M.S. Ladeira, D.M. Salvatore, M.A. Trevisan, J. Pedrazzoli Jr., and M.L. Ribeiro Influence of Helicobacter pylori infection on the expression of MLH1 and MGMT in patients with chronic gastritis and gastric cancer Eur. J. Clin. Microbiol. Infect. Dis. 28 2009 591 597
75. Y. Yao, H. Tao, D.I. Park, J.L. Sepulveda, and A.R. Sepulveda Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells Helicobacter 11 2006 272 286
76. S.P. Sajankila, P.V. Manthena, S. Adhikari, S. Choudhury, K. Izumi, and R. Roy Suppression of tumor suppressor Tsc2 and DNA repair glycosylase Nth1 during spontaneous liver tumorigenesis in Long-Evans Cinnamon rats Mol. Cell. Biochem. 338 2010 233 239
77. M. Jaiswal, N.F. LaRusso, N. Nishioka, Y. Nakabeppu, and G.J. Gores Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide Cancer Res. 61 2001 6388 6393
78. J. Liao, D.N. Seril, G.G. Lu, M. Zhang, S. Toyokuni, A.L. Yang, and G.Y. Yang Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice Mol. Carcinog. 47 2008 638 646
79. M. Kunisada, K. Sakumi, Y. Tominaga, A. Budiyanto, M. Ueda, M. Ichihashi, Y. Nakabeppu, and C. Nishigori 8-Oxoguanine formation induced by chronic UVB exposure makes Ogg1 knockout mice susceptible to skin carcinogenesis Cancer Res. 65 2005 6006 6010
80. S. Pal, S.J. Polyak, N. Bano, W.C. Qiu, R.L. Carithers, M. Shuhart, D.R. Gretch, and A. Das Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1 J. Gastroenterol. Hepatol. 25 2010 627 634
81. W. Xiao, and L. Samson In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells Proc. Natl. Acad. Sci. U. S. A. 90 1993 2117 2121
82. L.J. Hofseth, M.A. Khan, M. Ambrose, O. Nikolayeva, M. Xu-Welliver, M. Kartalou, S.P. Hussain, R.B. Roth, X. Zhou, L.E. Mechanic, I. Zurer, V. Rotter, L.D. Samson, and C.C. Harris The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation J. Clin. Invest. 112 2003 1887 1894
83. K. Ando, S. Hirao, Y. Kabe, Y. Ogura, I. Sato, Y. Yamaguchi, T. Wada, and H. Handa A new APE1/Ref-1-dependent pathway leading to reduction of NF-κB and AP-1, and activation of their DNA-binding activity Nucleic Acids Res. 36 2008 4327 4336
84. A. Jedinak, S. Dudhgaonkar, M.R. Kelley, and D. Sliva Apurinic/apyrimidinic endonuclease 1 regulates inflammatory response in macrophages Anticancer Res. 31 2011 379 385
85. Y. Zhang, Q. Liu, M. Zhang, Y. Yu, X. Liu, and X. Cao Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2 J. Immunol. 182 2009 3801 3808
86. O. Chornoguz, L. Grmai, P. Sinha, K.A. Artemenko, R.A. Zubarev, and S. Ostrand-Rosenberg Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis Mol. Cell. Proteomics 10 M110 2011 002980
87. S.K. Bunt, L. Yang, P. Sinha, V.K. Clements, J. Leips, and S. Ostrand-Rosenberg Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression Cancer Res. 67 2007 10019 10026
88. S.K. Bunt, V.K. Clements, E.M. Hanson, P. Sinha, and S. Ostrand-Rosenberg Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 J. Leukoc. Biol. 85 2009 996 1004
89. P. Sinha, V.K. Clements, A.M. Fulton, and S. Ostrand-Rosenberg Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Res. 67 2007 4507 4513
90. S. Tu, G. Bhagat, G. Cui, S. Takaishi, E.A. Kurt-Jones, B. Rickman, K.S. Betz, M. Penz-Oesterreicher, O. Bjorkdahl, J.G. Fox, and T.C. Wang Overexpression of interleukin-1β induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice Cancer Cell 14 2008 408 419
91. T. Kuilman, C. Michaloglou, L.C. Vredeveld, S. Douma, R. van Doorn, C.J. Desmet, L.A. Aarden, W.J. Mooi, and D.S. Peeper Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network Cell 133 2008 1019 1031
92. H. Lu, W. Ouyang, and C. Huang Inflammation, a key event in cancer development Mol. Cancer Res. 4 2006 221 233
93. C. Miki, Y. Inoue, T. Araki, K. Uchida, and M. Kusunoki Cytokines and cancer development J. Surg. Oncol. 95 2007 10 11
94. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J. Clin. Invest. 117 2007 1175 1183
95. M. Noguchi, N. Hiwatashi, Z. Liu, and T. Toyota Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease Gut 43 1998 203 209
96. R.J. Rigby, J.G. Simmons, C.J. Greenhalgh, W.S. Alexander, and P.K. Lund Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon Oncogene 26 2007 4833 4841
97. C. Tselepis, I. Perry, C. Dawson, R. Hardy, S.J. Darnton, C. McConkey, R.C. Stuart, N. Wright, R. Harrison, and J.A. Jankowski Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action Oncogene 21 2002 6071 6081
98. Y.C. Chung, and Y.F. Chang Serum interleukin-6 levels reflect the disease status of colorectal cancer J. Surg. Oncol. 83 2003 222 226
99. M.R. Schneider, A. Hoeflich, J.R. Fischer, E. Wolf, B. Sordat, and H. Lahm Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells Cancer Lett. 151 2000 31 38
100. B. Ancrile, K.H. Lim, and C.M. Counter Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis Genes Dev. 21 2007 1714 1719
101. V.B. Matthews, T.L. Allen, S. Risis, M.H. Chan, D.C. Henstridge, N. Watson, L.A. Zaffino, J.R. Babb, J. Boon, P.J. Meikle, J.B. Jowett, M.J. Watt, J.O. Jansson, C.R. Bruce, and M.A. Febbraio Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance Diabetologia 53 2010 2431 2441
102. H. Kai, Y. Kitadai, M. Kodama, S. Cho, T. Kuroda, M. Ito, S. Tanaka, Y. Ohmoto, and K. Chayama Involvement of proinflammatory cytokines IL-1β and IL-6 in progression of human gastric carcinoma Anticancer Res. 25 2005 709 713
103. J.H. Jeng, Y.J. Wang, B.L. Chiang, P.H. Lee, C.P. Chan, Y.S. Ho, T.M. Wang, J.J. Lee, L.J. Hahn, and M.C. Chang Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-α production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis 24 2003 1301 1315
104. Y. Li, C. de Haar, M. Chen, J. Deuring, M.M. Gerrits, R. Smits, B. Xia, E.J. Kuipers, and C.J. van der Woude Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis Gut 59 2010 227 235
105. H. Isomoto, J.L. Mott, S. Kobayashi, N.W. Werneburg, S.F. Bronk, S. Haan, and G.J. Gores Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing Gastroenterology 132 2007 384 396
106. Y. Rattigan, J.M. Hsu, P.J. Mishra, J. Glod, and D. Banerjee Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu Exp. Cell Res. 316 2010 3417 3424
107. G. Murugaiyan, and B. Saha Protumor vs antitumor functions of IL-17 J. Immunol. 183 2009 4169 4175
108. J.K. Kolls, and A. Linden Interleukin-17 family members and inflammation Immunity 21 2004 467 476
109. G.E. Steiner, M.E. Newman, D. Paikl, U. Stix, N. Memaran-Dagda, C. Lee, and M.J. Marberger Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate Prostate 56 2003 171 182
110. W.J. Chae, T.F. Gibson, D. Zelterman, L. Hao, O. Henegariu, and A.L. Bothwell Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 5540 5544
111. L. Wang, T. Yi, W. Zhang, D.M. Pardoll, and H. Yu IL-17 enhances tumor development in carcinogen-induced skin cancer Cancer Res. 70 2010 10112 10120
112. T. Iida, M. Iwahashi, M. Katsuda, K. Ishida, M. Nakamori, M. Nakamura, T. Naka, T. Ojima, K. Ueda, K. Hayata, Y. Nakamura, and H. Yamaue Tumor-infiltrating CD4 + Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer Oncol. Rep. 25 2011 1271 1277
113. J. Liu, Y. Duan, X. Cheng, X. Chen, W. Xie, H. Long, Z. Lin, and B. Zhu IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma Biochem. Biophys. Res. Commun. 407 2011 348 354
114. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4 + regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6 2005 345 352
115. C. Dong Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells Nat. Rev. Immunol. 6 2006 329 333
116. I. Kryczek, K. Wu, E. Zhao, S. Wei, L. Vatan, W. Szeliga, E. Huang, J. Greenson, A. Chang, J. Rolinski, P. Radwan, J. Fang, G. Wang, and W. Zou IL-17 + regulatory T cells in the microenvironments of chronic inflammation and cancer J. Immunol. 186 2011 4388 4395
117. H. Shime, M. Yabu, T. Akazawa, K. Kodama, M. Matsumoto, T. Seya, and N. Inoue Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway J. Immunol. 180 2008 7175 7183
118. R.N. Apte, and E. Voronov Interleukin-1 - a major pleiotropic cytokine in tumor-host interactions Semin. Cancer Biol. 12 2002 277 290
119. X. Li, J. Eckard, R. Shah, C. Malluck, and K. Frenkel Interleukin-1α up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses Cancer Res. 62 2002 417 423
120. D. Melisi, J. Niu, Z. Chang, Q. Xia, B. Peng, S. Ishiyama, D.B. Evans, and P.J. Chiao Secreted interleukin-1α induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-κB Mol. Cancer Res. 7 2009 624 633
121. J. Dambacher, F. Beigel, J. Seiderer, D. Haller, B. Goke, C.J. Auernhammer, and S. Brand Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease Gut 56 2007 1257 1265
122. F. Burke, M. Relf, R. Negus, and F. Balkwill A cytokine profile of normal and malignant ovary Cytokine 8 1996 578 585
123. M.S. Naylor, G.W. Stamp, W.D. Foulkes, D. Eccles, and F.R. Balkwill Tumor necrosis factor and its receptors in human ovarian cancer: potential role in disease progression J. Clin. Invest. 91 1993 2194 2206
124. L.A. Noach, N.B. Bosma, J. Jansen, F.J. Hoek, S.J. van Deventer, and G.N. Tytgat Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection Scand. J. Gastroenterol. 29 1994 425 429
125. M. Onizawa, T. Nagaishi, T. Kanai, K. Nagano, S. Oshima, Y. Nemoto, A. Yoshioka, T. Totsuka, R. Okamoto, T. Nakamura, N. Sakamoto, K. Tsuchiya, K. Aoki, K. Ohya, H. Yagita, and M. Watanabe Signaling pathway via TNF-α/NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis Am. J. Physiol. Gastrointest. Liver Physiol. 296 2009 G850 G859
126. H. Sakai, Y. Yamada, M. Shimizu, K. Saito, H. Moriwaki, and A. Hara Genetic ablation of Tnfα demonstrates no detectable suppressive effect on inflammation-related mouse colon tumorigenesis Chem. Biol. Interact. 184 2010 423 430
127. C.H. Arnott, K.A. Scott, R.J. Moore, S.C. Robinson, R.G. Thompson, and F.R. Balkwill Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development Oncogene 23 2004 1902 1910
128. R.J. Moore, D.M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, G. Kollias, and F. Balkwill Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis Nat. Med. 5 1999 828 831
129. F.M. Robertson, M.S. Ross, K.L. Tober, B.W. Long, and T.M. Oberyszyn Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline Carcinogenesis 17 1996 1719 1728
130. S.J. Allen, S.E. Crown, and T.M. Handel Chemokine: receptor structure, interactions, and antagonism Annu. Rev. Immunol. 25 2007 787 820
131. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
132. O. Kollmar, K. Rupertus, C. Scheuer, B. Junker, B. Tilton, M.K. Schilling, and M.D. Menger Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis Neoplasia 9 2007 862 870
133. J.D. Owen, R. Strieter, M. Burdick, H. Haghnegahdar, L. Nanney, R. Shattuck-Brandt, and A. Richmond Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins Int. J. Cancer 73 1997 94 103
134. Y. Yuecheng, and X. Xiaoyan Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2 Eur. J. Cancer Prev. 16 2007 430 435
135. P. Allavena, G. Germano, F. Marchesi, and A. Mantovani Chemokines in cancer related inflammation Exp. Cell Res. 317 2011 664 673
136. A. Sparmann, and D. Bar-Sagi Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis Cancer Cell 6 2004 447 458
137. J. Norgauer, B. Metzner, and I. Schraufstatter Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells J. Immunol. 156 1996 1132 1137
138. B. Bierie, C.H. Chung, J.S. Parker, D.G. Stover, N. Cheng, A. Chytil, M. Aakre, Y. Shyr, and H.L. Moses Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer J. Clin. Invest. 119 2009 1571 1582
139. T. Schioppa, B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo, and A. Sica Regulation of the chemokine receptor CXCR4 by hypoxia J. Exp. Med. 198 2003 1391 1402
140. S. Vetrano, E.M. Borroni, A. Sarukhan, B. Savino, R. Bonecchi, C. Correale, V. Arena, M. Fantini, M. Roncalli, A. Malesci, A. Mantovani, M. Locati, and S. Danese The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 Gut 59 2010 197 206
141. F. Balkwill Cancer and the chemokine network Nat. Rev. Cancer 4 2004 540 550
142. E. Schutyser, S. Struyf, P. Proost, G. Opdenakker, G. Laureys, B. Verhasselt, L. Peperstraete, I. Van de Putte, A. Saccani, P. Allavena, A. Mantovani, and J. Van Damme Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma J. Biol. Chem. 277 2002 24584 24593
143. Y. Sawanobori, S. Ueha, M. Kurachi, T. Shimaoka, J.E. Talmadge, J. Abe, Y. Shono, M. Kitabatake, K. Kakimi, N. Mukaida, and K. Matsushima Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice Blood 111 2008 5457 5466
144. S. Ostrand-Rosenberg, and P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J. Immunol. 182 2009 4499 4506
145. D.S. Wen, X.L. Zhu, S.M. Guan, Y.M. Wu, L.L. Yu, and J.Z. Wu Silencing of CXCR4 inhibits the proliferation, adhesion, chemotaxis and invasion of salivary gland mucoepidermoid carcinoma Mc3 cells in vitro Oral Oncol. 44 2008 545 554
146. Y.J. Surh, and J.K. Kundu Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression Curr. Cancer Drug Targets 7 2007 447 458
147. Y.J. Surh, K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park, and S.S. Lee Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation Mutat. Res. 480-481 2001 243 268
148. K. Muller-Decker, G. Neufang, I. Berger, M. Neumann, F. Marks, and G. Furstenberger Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis Proc. Natl. Acad. Sci. U. S. A. 99 2002 12483 12488
149. G. Neufang, G. Furstenberger, M. Heidt, F. Marks, and K. Muller-Decker Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin Proc. Natl. Acad. Sci. U. S. A. 98 2001 7629 7634
150. H. Oshima, M. Oshima, K. Inaba, and M.M. Taketo Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice EMBO J. 23 2004 1669 1678
151. M. Oshima, J.E. Dinchuk, S.L. Kargman, H. Oshima, B. Hancock, E. Kwong, J.M. Trzaskos, J.F. Evans, and M.M. Taketo Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell 87 1996 803 809
152. H.F. Tiano, C.D. Loftin, J. Akunda, C.A. Lee, J. Spalding, A. Sessoms, D.B. Dunson, E.G. Rogan, S.G. Morham, R.C. Smart, and R. Langenbach Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis Cancer Res. 62 2002 3395 3401
153. L.R. Howe, S.H. Chang, K.C. Tolle, R. Dillon, L.J. Young, R.D. Cardiff, R.A. Newman, P. Yang, H.T. Thaler, W.J. Muller, C. Hudis, A.M. Brown, T. Hla, K. Subbaramaiah, and A.J. Dannenberg HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice Cancer Res. 65 2005 10113 10119
154. S.M. Fischer, A. Pavone, C. Mikulec, R. Langenbach, and J.E. Rundhaug Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis Mol. Carcinog. 46 2007 363 371
155. R.D. Klein, C.S. Van Pelt, A.L. Sabichi, J. Dela Cerda, S.M. Fischer, G. Furstenberger, and K. Muller-Decker Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression Cancer Res. 65 2005 1808 1813
156. J.W. Tjiu, Y.H. Liao, S.J. Lin, Y.L. Huang, W.L. Tsai, C.Y. Chu, M.L. Kuo, and S.H. Jee Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis J. Invest. Dermatol. 126 2006 1143 1151
157. K. Oyama, T. Fujimura, I. Ninomiya, T. Miyashita, S. Kinami, S. Fushida, T. Ohta, and M. Koichi A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats Carcinogenesis 26 2005 565 570
158. E.H. Kim, H.K. Na, D.H. Kim, S.A. Park, H.N. Kim, N.Y. Song, and Y.J. Surh 15-Deoxy-Δ12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS Carcinogenesis 29 2008 688 695
159. O. Millan, D. Rico, H. Peinado, N. Zarich, K. Stamatakis, D. Perez-Sala, J.M. Rojas, A. Cano, and L. Bosca Potentiation of tumor formation by topical administration of 15-deoxy-Δ12,14-prostaglandin J2 in a model of skin carcinogenesis Carcinogenesis 27 2006 328 336
160. S. Giri, R. Rattan, A.K. Singh, and I. Singh The 15-deoxy-Δ12,14- prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF- κB-p300 pathway independent of peroxisome proliferator-activated receptor γ J. Immunol. 173 2004 5196 5208
161. H. Vunta, F. Davis, U.D. Palempalli, D. Bhat, R.J. Arner, J.T. Thompson, D.G. Peterson, C.C. Reddy, and K.S. Prabhu The anti-inflammatory effects of selenium are mediated through 15-deoxy-Δ12,14-prostaglandin J2 in macrophages J. Biol. Chem. 282 2007 17964 17973
162. D.H. Kim, J.H. Kim, E.H. Kim, H.K. Na, Y.N. Cha, J.H. Chung, and Y.J. Surh 15-Deoxy-Δ12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS Carcinogenesis 30 2009 645 654
163. E.H. Kim, H.K. Na, and Y.J. Surh Upregulation of VEGF by 15-deoxy-Δ12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells Ann. N. Y. Acad. Sci. 1090 2006 375 384
164. D.H. Kim, E.H. Kim, H.K. Na, Y. Sun, and Y.J. Surh 15-Deoxy-Δ(12, 14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue Oncogene 29 2010 2560 2576
165. D.S. Straus, G. Pascual, M. Li, J.S. Welch, M. Ricote, C.H. Hsiang, L.L. Sengchanthalangsy, G. Ghosh, and C.K. Glass 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway Proc. Natl. Acad. Sci. U. S. A. 97 2000 4844 4849
166. M. Hilliard, C. Frohnert, C. Spillner, S. Marcone, A. Nath, T. Lampe, D.J. Fitzgerald, and R.H. Kehlenbach The anti-inflammatory prostaglandin 15-deoxy-Δ(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein export J. Biol. Chem. 285 2010 22202 22210
167. B.C. Jang, U. Munoz-Najar, J.H. Paik, K. Claffey, M. Yoshida, and T. Hla Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression J. Biol. Chem. 278 2003 2773 2776
168. B.C. Jang, S.H. Sung, J.G. Park, J.W. Park, M.H. Suh, I.H. Choi, M. Yoshida, S.K. Yoo, and S.I. Suh Leptomycin B, a metabolite of Streptomyces, inhibits the expression of inducible nitric oxide synthase in BV2 microglial cells Int. J. Oncol. 29 2006 1509 1515
169. G. Furstenberger, M. Gross, and F. Marks Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion) Carcinogenesis 10 1989 91 96
170. T. Narisawa, M. Takahashi, M. Niwa, Y. Fukaura, and A. Wakizaka Involvement of prostaglandin E2 in bile acid-caused promotion of colon carcinogenesis and anti-promotion by the cyclooxygenase inhibitor indomethacin Jpn. J. Cancer Res. 78 1987 791 798
171. M. Mutoh, K. Watanabe, T. Kitamura, Y. Shoji, M. Takahashi, T. Kawamori, K. Tani, M. Kobayashi, T. Maruyama, K. Kobayashi, S. Ohuchida, Y. Sugimoto, S. Narumiya, T. Sugimura, and K. Wakabayashi Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis Cancer Res. 62 2002 28 32
172. K. Watanabe, T. Kawamori, S. Nakatsugi, T. Ohta, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, F. Ushikubi, S. Narumiya, T. Sugimura, and K. Wakabayashi Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis Cancer Res. 59 1999 5093 5096
173. M. Sonoshita, K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, S. Narumiya, M. Oshima, and M.M. Taketo Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Δ716) knockout mice Nat. Med. 7 2001 1048 1051
174. D.P. Cherukuri, X.B. Chen, A.C. Goulet, R.N. Young, Y. Han, R.L. Heimark, J.W. Regan, E. Meuillet, and M.A. Nelson The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells Exp. Cell Res. 313 2007 2969 2979
175. A.R. Munkarah, R. Morris, P. Baumann, G. Deppe, J. Malone, M.P. Diamond, and G.M. Saed Effects of prostaglandin E2 on proliferation and apoptosis of epithelial ovarian cancer cells J. Soc. Gynecol. Investig. 9 2002 168 173
176. L. Qiao, V. Kozoni, G.J. Tsioulias, M.I. Koutsos, R. Hanif, S.J. Shiff, and B. Rigas Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo Biochim. Biophys. Acta 1258 1995 215 223
177. R.R. Tjandrawinata, and M. Hughes-Fulford Up-regulation of cyclooxygenase-2 by-product prostaglandin E2 Adv. Exp. Med. Biol. 407 1997 163 170
178. D. Wolfle Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F(2α) Toxicology 188 2003 139 147
179. A.E. Wallace, K.J. Sales, R.D. Catalano, R.A. Anderson, A.R. Williams, M.R. Wilson, J. Schwarze, H. Wang, A.G. Rossi, and H.N. Jabbour Prostaglandin F2α-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma Cancer Res. 69 2009 5726 5733
180. K.J. Sales, D. Maldonado-Perez, V. Grant, R.D. Catalano, M.R. Wilson, P. Brown, A.R. Williams, R.A. Anderson, E.A. Thompson, and H.N. Jabbour Prostaglandin F(2α)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway Biochim. Biophys. Acta 1793 2009 1917 1928
181. K.J. Sales, V. Grant, and H.N. Jabbour Prostaglandin E2 and F2α activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element Mol. Cell. Endocrinol. 285 2008 51 61
182. K.J. Sales, T. List, S.C. Boddy, A.R. Williams, R.A. Anderson, Z. Naor, and H.N. Jabbour A novel angiogenic role for prostaglandin F2α-FP receptor interaction in human endometrial adenocarcinomas Cancer Res. 65 2005 7707 7716
183. D. Qualtrough, A. Kaidi, S. Chell, H.N. Jabbour, A.C. Williams, and C. Paraskeva Prostaglandin F(2α) stimulates motility and invasion in colorectal tumor cells Int. J. Cancer 121 2007 734 740
184. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, V. Boddi, V. Chiarugi, and E. Masini Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis Neoplasia 3 2001 53 61
185. S.P. Huang, M.S. Wu, C.T. Shun, H.P. Wang, C.Y. Hsieh, M.L. Kuo, and J.T. Lin Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma J. Biomed. Sci. 12 2005 229 241
186. Y.B. Ding, R.H. Shi, J.D. Tong, X.Y. Li, G.X. Zhang, W.M. Xiao, J.G. Yang, Y. Bao, J. Wu, Z.G. Yan, and X.H. Wang PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system Exp. Oncol. 27 2005 108 113
187. H. Amano, I. Hayashi, H. Endo, H. Kitasato, S. Yamashina, T. Maruyama, M. Kobayashi, K. Satoh, M. Narita, Y. Sugimoto, T. Murata, H. Yoshimura, S. Narumiya, and M. Majima Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth J. Exp. Med. 197 2003 221 232
188. M. Kamiyama, A. Pozzi, L. Yang, L.M. DeBusk, R.M. Breyer, and P.C. Lin EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival Oncogene 25 2006 7019 7028
189. S. Mariotto, M. Menegazzi, and H. Suzuki Biochemical aspects of nitric oxide Curr. Pharm. Des. 10 2004 1627 1645
190. L. Leon, J.F. Jeannin, and A. Bettaieb Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis Nitric Oxide 19 2008 77 83
191. M. Jaiswal, N.F. LaRusso, and G.J. Gores Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis Am. J. Physiol. Gastrointest. Liver Physiol. 281 2001 G626 G634
192. T. Chen, and G.D. Stoner Inducible nitric oxide synthase expression in N-nitrosomethylbenzylamine (NMBA)-induced rat esophageal tumorigenesis Mol. Carcinog. 40 2004 232 240
193. J.S. Beckman Oxidative damage and tyrosine nitration from peroxynitrite Chem. Res. Toxicol. 9 1996 836 844
194. K.T. Wilson, S. Fu, K.S. Ramanujam, and S.J. Meltzer Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas Cancer Res. 58 1998 2929 2934
195. N.M. Vaninetti, L. Geldenhuys, G.A. Porter, H. Risch, P. Hainaut, D.L. Guernsey, and A.G. Casson Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma Mol. Carcinog. 47 2008 275 285
196. S.H. Aaltoma, P.K. Lipponen, and V.M. Kosma Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer Anticancer Res. 21 2001 3101 3106
197. G. Rieder, J.A. Hofmann, R.A. Hatz, M. Stolte, and G.A. Enders Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type Int. J. Med. Microbiol. 293 2003 403 412
198. D.A. Wink, Y. Vodovotz, J. Laval, F. Laval, M.W. Dewhirst, and J.B. Mitchell The multifaceted roles of nitric oxide in cancer Carcinogenesis 19 1998 711 721
199. T. Tanaka, H. Kohno, R. Suzuki, K. Hata, S. Sugie, N. Niho, K. Sakano, M. Takahashi, and K. Wakabayashi Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms Int. J. Cancer 118 2006 25 34
200. H. Kohno, M. Takahashi, Y. Yasui, R. Suzuki, S. Miyamoto, Y. Kamanaka, M. Naka, T. Maruyama, K. Wakabayashi, and T. Tanaka A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice Int. J. Cancer 121 2007 506 513
201. K.S. Chun, H.H. Cha, J.W. Shin, H.K. Na, K.K. Park, W.Y. Chung, and Y.J. Surh Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-κB Carcinogenesis 25 2004 445 454
202. L.J. Hofseth, A.I. Robles, M.G. Espey, and C.C. Harris Nitric oxide is a signaling molecule that regulates gene expression Methods Enzymol. 396 2005 326 340
203. S.P. Hussain, G.E. Trivers, L.J. Hofseth, P. He, I. Shaikh, L.E. Mechanic, S. Doja, W. Jiang, J. Subleski, L. Shorts, D. Haines, V.E. Laubach, R.H. Wiltrout, D. Djurickovic, and C.C. Harris Nitric oxide, a mediator of inflammation, suppresses tumorigenesis Cancer Res. 64 2004 6849 6853
204. P.K. Lala, and A. Orucevic Role of nitric oxide in tumor progression: lessons from experimental tumors Cancer Metastasis Rev. 17 1998 91 106
205. Y. Ishii, T. Ogura, M. Tatemichi, H. Fujisawa, F. Otsuka, and H. Esumi Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines Int. J. Cancer 103 2003 161 168
206. L. Ying, A.B. Hofseth, D.D. Browning, M. Nagarkatti, P.S. Nagarkatti, and L.J. Hofseth Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation Cancer Res. 67 2007 9286 9293
207. A.K. Iyer, N. Azad, L. Wang, and Y. Rojanasakul Role of S-nitrosylation in apoptosis resistance and carcinogenesis Nitric Oxide 19 2008 146 151
208. N.J. Torok, H. Higuchi, S. Bronk, and G.J. Gores Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9 Cancer Res. 62 2002 1648 1653
209. S. Ambs, W.G. Merriam, M.O. Ogunfusika, W.P. Bennett, N. Ishibe, S.P. Hussain, E.E. Tzeng, D.A. Geller, T.R. Billiar, and C.C. Harris p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells Nat. Med. 4 1998 1371 1376
210. C.S. Cobbs, M. Samanta, L.E. Harkins, G.Y. Gillespie, B.A. Merrick, and L.A. MacMillan-Crow Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences Arch. Biochem. Biophys. 394 2001 167 172
211. C.M. Schonhoff, M.C. Daou, S.N. Jones, C.A. Schiffer, and A.H. Ross Nitric oxide-mediated inhibition of Hdm2-p53 binding Biochemistry 41 2002 13570 13574
212. K. Forrester, S. Ambs, S.E. Lupold, R.B. Kapust, E.A. Spillare, W.C. Weinberg, E. Felley-Bosco, X.W. Wang, D.A. Geller, E. Tzeng, T.R. Billiar, and C.C. Harris Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53 Proc. Natl. Acad. Sci. U. S. A. 93 1996 2442 2447
213. K.B. Sandau, H.G. Faus, and B. Brune Induction of hypoxia-inducible- factor 1 by nitric oxide is mediated via the PI 3K pathway Biochem. Biophys. Res. Commun. 278 2000 263 267
214. F. Li, P. Sonveaux, Z.N. Rabbani, S. Liu, B. Yan, Q. Huang, Z. Vujaskovic, M.W. Dewhirst, and C.Y. Li Regulation of HIF-1α stability through S-nitrosylation Mol. Cell 26 2007 63 74
215. R. Ravi, B. Mookerjee, Z.M. Bhujwalla, C.H. Sutter, D. Artemov, Q. Zeng, L.E. Dillehay, A. Madan, G.L. Semenza, and A. Bedi Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α Genes Dev. 14 2000 34 44
216. L.R. Kisley, B.S. Barrett, A.K. Bauer, L.D. Dwyer-Nield, B. Barthel, A.M. Meyer, D.C. Thompson, and A.M. Malkinson Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis Cancer Res. 62 2002 6850 6856
217. R. Zhang, A. Ma, S.J. Urbanski, and D.M. McCafferty Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma Carcinogenesis 28 2007 1122 1130
218. D.N. Seril, J. Liao, and G.Y. Yang Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis Mol. Carcinog. 46 2007 341 353
219. R. Heller, T. Polack, R. Grabner, and U. Till Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP Atherosclerosis 144 1999 49 57
220. Y. Kanamaru, T. Takada, R. Saura, and K. Mizuno Effect of nitric oxide on mouse clonal osteogenic cell, MC3T3-E1, proliferation in vitro Kobe J. Med. Sci. 47 2001 1 11
221. I. Marenholz, C.W. Heizmann, and G. Fritz S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature) Biochem. Biophys. Res. Commun. 322 2004 1111 1122
222. J.M. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and J. Roth The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer J. Leukoc. Biol. 86 2009 557 566
223. O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, J. Nayak, M. Nguyen, A. Olsson, P.P. Nawroth, A. Bierhaus, N. Varki, M. Kronenberg, H.H. Freeze, and G. Srikrishna RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis Carcinogenesis 29 2008 2035 2043
224. I.C. Lawrance, C. Fiocchi, and S. Chakravarti Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes Hum. Mol. Genet. 10 2001 445 456
225. C. Taccioli, S.G. Wan, C.G. Liu, H. Alder, S. Volinia, J.L. Farber, C.M. Croce, and L.Y. Fong Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat Gastroenterology 136 2009 953 966
226. Y.J. Su, F. Xu, J.P. Yu, D.S. Yue, X.B. Ren, and C.L. Wang Up-regulation of the expression of S100A8 and S100A9 in lung adenocarcinoma and its correlation with inflammation and other clinical features Chin. Med. J. (Engl) 123 2010 2215 2220
227. A. Saha, Y.C. Lee, Z. Zhang, G. Chandra, S.B. Su, and A.B. Mukherjee Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs J. Biol. Chem. 285 2010 10822 10831
228. C. Gebhardt, U. Breitenbach, J.P. Tuckermann, B.T. Dittrich, K.H. Richter, and P. Angel Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis Oncogene 21 2002 4266 4276
229. M. Webb, E.D. Emberley, M. Lizardo, S. Alowami, G. Qing, A. Alfia'ar, L.J. Snell-Curtis, Y. Niu, A. Civetta, Y. Myal, R. Shiu, L.C. Murphy, and P.H. Watson Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis BMC Cancer 5 2005 17
230. S.A. Lund, C.M. Giachelli, and M. Scatena The role of osteopontin in inflammatory processes J. Cell Commun. Signal. 3 2009 311 322
231. R. Pichler, C.M. Giachelli, D. Lombardi, J. Pippin, K. Gordon, C.E. Alpers, S.M. Schwartz, and R.J. Johnson Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin) Am. J. Pathol. 144 1994 915 926
232. L.F. Brown, A. Papadopoulos-Sergiou, B. Berse, E.J. Manseau, K. Tognazzi, C.A. Perruzzi, H.F. Dvorak, and D.R. Senger Osteopontin expression and distribution in human carcinomas Am. J. Pathol. 145 1994 610 623
233. C.M. Giachelli, D. Lombardi, R.J. Johnson, C.E. Murry, and M. Almeida Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo Am. J. Pathol. 152 1998 353 358
234. N.A. Atai, M. Bansal, C. Lo, J. Bosman, W. Tigchelaar, K.S. Bosch, A. Jonker, P.C. De Witt Hamer, D. Troost, C.A. McCulloch, V. Everts, C.J. Van Noorden, and J. Sodek Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma Immunology 132 2011 39 48
235. P.L. Chang, M. Cao, and P. Hicks Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells Carcinogenesis 24 2003 1749 1758
236. E.I. Behrend, A.M. Craig, S.M. Wilson, D.T. Denhardt, and A.F. Chambers Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA Cancer Res. 54 1994 832 837
237. H. Tang, J. Wang, F. Bai, L. Hong, J. Liang, J. Gao, H. Zhai, M. Lan, F. Zhang, K. Wu, and D. Fan Inhibition of osteopontin would suppress angiogenesis in gastric cancer Biochem. Cell Biol. 85 2007 103 110
238. M. Hirama, F. Takahashi, K. Takahashi, S. Akutagawa, K. Shimizu, S. Soma, Y. Shimanuki, K. Nishio, and Y. Fukuchi Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth Cancer Lett. 198 2003 107 117
239. S. Philip, A. Bulbule, and G.C. Kundu Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells J. Biol. Chem. 276 2001 44926 44935
240. S. Jain, G. Chakraborty, and G.C. Kundu The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C α/c-Src/IκB kinase α/β-dependent prostate tumor progression and angiogenesis Cancer Res. 66 2006 6638 6648
241. R. Das, G.H. Mahabeleshwar, and G.C. Kundu Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells J. Biol. Chem. 279 2004 11051 11064
242. Z. Mi, S.D. Bhattacharya, V.M. Kim, H. Guo, L.J. Talbot, and P.C. Kuo Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis Carcinogenesis 32 2011 477 487
243. M.T. Elola, C. Wolfenstein-Todel, M.F. Troncoso, G.R. Vasta, and G.A. Rabinovich Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival Cell. Mol. Life Sci. 64 2007 1679 1700
244. S. Sangaletti, and M.P. Colombo Matricellular proteins at the crossroad of inflammation and cancer Cancer Lett. 267 2008 245 253
245. J.M. Ilarregui, G.A. Bianco, M.A. Toscano, and G.A. Rabinovich The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders Ann. Rheum. Dis. 64 Suppl. 4 2005 iv96 iv103
246. P.M. Alves, G.P. Godoy, D.Q. Gomes, A.M. Medeiros, L.B. de Souza, E.J. da Silveira, M.G. Vasconcelos, and L.M. Queiroz Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue Pathol. Res. Pract. 207 2011 236 240
247. M.V. Espelt, D.O. Croci, M.L. Bacigalupo, P. Carabias, M. Manzi, M.T. Elola, M.C. Munoz, F.P. Dominici, C. Wolfenstein-Todel, G.A. Rabinovich, and M.F. Troncoso Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth Hepatology 53 2011 2097 2106
248. G.A. Rabinovich Galectin-1 as a potential cancer target Br. J. Cancer 92 2005 1188 1192
249. P. Vereecken, K. Zouaoui Boudjeltia, C. Debray, A. Awada, I. Legssyer, F. Sales, M. Petein, M. Vanhaeverbeek, G. Ghanem, and M. Heenen High serum galectin-3 in advanced melanoma: preliminary results Clin. Exp. Dermatol. 31 2006 105 109
250. M.K. Kim, C.O. Sung, I.G. Do, H.K. Jeon, T.J. Song, H.S. Park, Y.Y. Lee, B.G. Kim, J.W. Lee, and D.S. Bae Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma Int. J. Clin. Oncol. 16 2011 352 358
251. T.T. Htwe, N. Karim, J. Wong, S. Jahanfar, and M.A. Mansur Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis Singapore Med. J. 51 2010 856 859
252. T. Kobayashi, T. Shimura, T. Yajima, N. Kubo, K. Araki, S. Tsutsumi, H. Suzuki, H. Kuwano, and A. Raz Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin Int. J. Cancer 129 2011 2775 2786
253. K.M. Rumilla, L.A. Erickson, A.K. Erickson, and R.V. Lloyd Galectin-4 expression in carcinoid tumors Endocr. Pathol. 17 2006 243 249
254. D. Cooper, L.V. Norling, and M. Perretti Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow J. Leukoc. Biol. 83 2008 1459 1466
255. L. Santucci, S. Fiorucci, N. Rubinstein, A. Mencarelli, B. Palazzetti, B. Federici, G.A. Rabinovich, and A. Morelli Galectin-1 suppresses experimental colitis in mice Gastroenterology 124 2003 1381 1394
256. D. Paclik, S. Danese, U. Berndt, B. Wiedenmann, A. Dignass, and A. Sturm Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle PLoS One 3 2008 e2629
257. M.I. Filipe, A. Sandey, and J. Ma Intestinal mucin antigens in ulcerative colitis and their relationship with malignancy Hum. Pathol. 19 1988 671 681
258. H. Hoshi, T. Sawada, M. Uchida, H. Saito, H. Iijima, M. Toda-Agetsuma, T. Wada, S. Yamazoe, H. Tanaka, K. Kimura, A. Kakehashi, M. Wei, K. Hirakawa, and H. Wanibuchi Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer Int. J. Oncol. 38 2011 619 627
259. D.W. Kufe Mucins in cancer: function, prognosis and therapy Nat. Rev. Cancer 9 2009 874 885
260. A.P. Femia, P. Dolara, C. Luceri, M. Salvadori, and G. Caderni Mucin-depleted foci show strong activation of inflammatory markers in 1,2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate Int. J. Cancer 125 2009 541 547
261. W.C. Chung, S.H. Ryu, H. Sun, D.C. Zeldin, and J.S. Koo CREB mediates prostaglandin F2α-induced MUC5AC overexpression J. Immunol. 182 2009 2349 2356
262. P.L. Beatty, S. Narayanan, J. Gariepy, S. Ranganathan, and O.J. Finn Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer Cancer Prev. Res. (Philadelphia) 3 2010 438 446
263. R. Mejias-Luque, S.K. Linden, M. Garrido, H. Tye, M. Najdovska, B.J. Jenkins, M. Iglesias, M. Ernst, and C. de Bolos Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors Oncogene 29 2010 1753 1762
264. W.R. Matull, F. Andreola, A. Loh, Z. Adiguzel, M. Deheragoda, U. Qureshi, S.K. Batra, D.M. Swallow, and S.P. Pereira MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer Br. J. Cancer 98 2008 1675 1681
265. Y.H. Sheng, R. Lourie, S.K. Linden, P.L. Jeffery, D. Roche, T.V. Tran, C.W. Png, N. Waterhouse, P. Sutton, T.H. Florin, and M.A. McGuckin The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis Gut 60 2011 1661 1670
266. K. Yang, N.V. Popova, W.C. Yang, I. Lozonschi, S. Tadesse, S. Kent, L. Bancroft, I. Matise, R.T. Cormier, S.J. Scherer, W. Edelmann, M. Lipkin, L. Augenlicht, and A. Velcich Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation Cancer Res. 68 2008 7313 7322
267. M. Karin How NF-κB is activated: the role of the IκB kinase (IKK) complex Oncogene 18 1999 6867 6874
268. Y.J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780
269. M.M. Chaturvedi, B. Sung, V.R. Yadav, R. Kannappan, and B.B. Aggarwal NF-κB addiction and its role in cancer: 'one size does not fit all' Oncogene 30 2011 1615 1630
270. J.K. Kundu, and Y.J. Surh Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals Mutat. Res. 591 2005 123 146
271. S.C. Gupta, J.H. Kim, R. Kannappan, S. Reuter, P.M. Dougherty, and B.B. Aggarwal Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents Exp. Biol. Med. (Maywood) 236 2011 658 671
272. Q.W. Xie, Y. Kashiwabara, and C. Nathan Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase J. Biol. Chem. 269 1994 4705 4708
273. R. Newton, L.M. Kuitert, M. Bergmann, I.M. Adcock, and P.J. Barnes Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β Biochem. Biophys. Res. Commun. 237 1997 28 32
274. J.H. Joo, J.W. Kim, Y. Lee, S.Y. Yoon, J.H. Kim, S.G. Paik, and I.S. Choe Involvement of NF-κB in the regulation of S100A6 gene expression in human hepatoblastoma cell line HepG2 Biochem. Biophys. Res. Commun. 307 2003 274 280
275. J. Nemeth, I. Stein, D. Haag, A. Riehl, T. Longerich, E. Horwitz, K. Breuhahn, C. Gebhardt, P. Schirmacher, M. Hahn, Y. Ben-Neriah, E. Pikarsky, P. Angel, and J. Hess S100A8 and S100A9 are novel nuclear factor κB target genes during malignant progression of murine and human liver carcinogenesis Hepatology 50 2009 1251 1262
276. M.A. Renault, S. Jalvy, M. Potier, I. Belloc, E. Genot, L.V. Dekker, C. Desgranges, and A.P. Gadeau UTP induces osteopontin expression through a coordinate action of NFκB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells J. Biol. Chem. 280 2005 2708 2713
277. Y.T. Li, B. He, Y.Z. Wang, and J. Wang Effects of intratracheal administration of nuclear factor-κB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice Respir. Res. 10 2009 79
278. D. De Stefano, G. De Rosa, M.C. Maiuri, F. Ungaro, F. Quaglia, T. Iuvone, M.P. Cinelli, M.I. La Rotonda, and R. Carnuccio Oligonucleotide decoy to NF-κB slowly released from PLGA microspheres reduces chronic inflammation in rat Pharmacol. Res. 60 2009 33 40
279. C.G. De Vry, S. Prasad, L. Komuves, C. Lorenzana, C. Parham, T. Le, S. Adda, J. Hoffman, N. Kahoud, R. Garlapati, R. Shyamsundar, K. Mai, J. Zhang, T. Muchamuel, M. Dajee, B. Schryver, L.M. McEvoy, and R.O. Ehrhardt Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis Gut 56 2007 524 533
280. T. Wang, Q.H. Li, G.P. Hao, and J. Zhai Antitumor activity of decoy oligodeoxynucleotides targeted to NF-κB in vitro and in vivo Asian Pac. J. Cancer Prev. 11 2010 193 200
281. F.R. Greten, L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, L.J. Egan, M.F. Kagnoff, and M. Karin IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296
282. P. Angel, and M. Karin The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation Biochim. Biophys. Acta 1072 1991 129 157
283. R. Wisdom AP-1: one switch for many signals Exp. Cell Res. 253 1999 180 185
284. P. Angel, M. Imagawa, R. Chiu, B. Stein, R.J. Imbra, H.J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor Cell 49 1987 729 739
285. T.D. Halazonetis, K. Georgopoulos, M.E. Greenberg, and P. Leder c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities Cell 55 1988 917 924
286. I. Moriyama, S. Ishihara, M.A. Rumi, M.D. Aziz, Y. Mishima, N. Oshima, C. Kadota, Y. Kadowaki, Y. Amano, and Y. Kinoshita Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis Lab. Invest. 88 2008 652 663
287. Y.G. Park, M. Nesterova, S. Agrawal, and Y.S. Cho-Chung Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide: gene-specific inhibition of tumor growth J. Biol. Chem. 274 1999 1573 1580
288. Z. Zhong, Z. Wen, and J.E. Darnell Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 Science 264 1994 95 98
289. D.J. Kim, K.S. Chan, S. Sano, and J. Digiovanni Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis Mol. Carcinog. 46 2007 725 731
290. C.S. Lai, S. Li, C.Y. Chai, C.Y. Lo, C.T. Ho, Y.J. Wang, and M.H. Pan Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′,4′- hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice Carcinogenesis 28 2007 2581 2588
291. J. Youn, J.S. Lee, H.K. Na, J.K. Kundu, and Y.J. Surh Resveratrol and piceatannol inhibit iNOS expression and NF-κB activation in dextran sulfate sodium-induced mouse colitis Nutr. Cancer 61 2009 847 854
292. H. Lee, J. Deng, M. Kujawski, C. Yang, Y. Liu, A. Herrmann, M. Kortylewski, D. Horne, G. Somlo, S. Forman, R. Jove, and H. Yu STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors Nat. Med. 16 2010 1421 1428
293. Y. Li, H. Du, Y. Qin, J. Roberts, O.W. Cummings, and C. Yan Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung Cancer Res. 67 2007 8494 8503
294. L.M. Judd, K. Bredin, A. Kalantzis, B.J. Jenkins, M. Ernst, and A.S. Giraud STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis Gastroenterology 131 2006 1073 1085
295. K.S. Chan, S. Sano, K. Kiguchi, J. Anders, N. Komazawa, J. Takeda, and J. DiGiovanni Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis J. Clin. Invest. 114 2004 720 728
296. N. Ma, M. Kawanishi, Y. Hiraku, M. Murata, G.W. Huang, Y. Huang, D.Z. Luo, W.G. Mo, Y. Fukui, and S. Kawanishi Reactive nitrogen species-dependent DNA
297. B.B. Aggarwal, G. Sethi, K.S. Ahn, S.K. Sandur, M.K. Pandey, A.B. Kunnumakkara, B. Sung, and H. Ichikawa Targeting signal-transducer-and- activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution Ann. N. Y. Acad. Sci. 1091 2006 151 169
298. P.L. Leong, G.A. Andrews, D.E. Johnson, K.F. Dyer, S. Xi, J.C. Mai, P.D. Robbins, S. Gadiparthi, N.A. Burke, S.F. Watkins, and J.R. Grandis Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth Proc. Natl. Acad. Sci. U. S. A. 100 2003 4138 4143
299. C. Brigati, B. Banelli, A. di Vinci, I. Casciano, G. Allemanni, A. Forlani, L. Borzi, and M. Romani Inflammation, HIF-1, and the epigenetics that follows Mediators Inflamm. 2010 2010 263914
300. D. Liao, and R.S. Johnson Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev. 26 2007 281 290
301. P.M. Elks, F.J. van Eeden, G. Dixon, X. Wang, C.C. Reyes-Aldasoro, P.W. Ingham, M.K. Whyte, S.R. Walmsley, and S.A. Renshaw Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model Blood 118 2011 712 722
302. F.C. Ling, J. Khochfar, S.E. Baldus, J. Brabender, U. Drebber, E. Bollschweiler, A.H. Hoelscher, and P.M. Schneider HIF-1α protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia Dis. Esophagus 22 2009 694 699
303. F. Mariani, P. Sena, L. Marzona, M. Riccio, R. Fano, P. Manni, C.D. Gregorio, A. Pezzi, M.P. Leon, S. Monni, A.D. Pol, and L. Roncucci Cyclooxygenase-2 and hypoxia-inducible factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis Cancer Lett. 279 2009 221 229
304. Y.J. Jung, J.S. Isaacs, S. Lee, J. Trepel, and L. Neckers IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis FASEB J. 17 2003 2115 2117
305. H.Z. Imtiyaz, E.P. Williams, M.M. Hickey, S.A. Patel, A.C. Durham, L.J. Yuan, R. Hammond, P.A. Gimotty, B. Keith, and M.C. Simon Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammation J. Clin. Invest. 120 2010 2699 2714
306. H. Lee, A. Herrmann, J.H. Deng, M. Kujawski, G. Niu, Z. Li, S. Forman, R. Jove, D.M. Pardoll, and H. Yu Persistently activated Stat3 maintains constitutive NF-κB activity in tumors Cancer Cell 15 2009 283 293
307. J. Bollrath, and F.R. Greten IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis EMBO Rep. 10 2009 1314 1319
308. B. Huang, Z. Lei, G.M. Zhang, D. Li, C. Song, B. Li, Y. Liu, Y. Yuan, J. Unkeless, H. Xiong, and Z.H. Feng SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment Blood 112 2008 1269 1279
309. K. Salnikow, T. Kluz, M. Costa, D. Piquemal, Z.N. Demidenko, K. Xie, and M.V. Blagosklonny The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia Mol. Cell. Biol. 22 2002 1734 1741
310. G. Niu, J. Briggs, J. Deng, Y. Ma, H. Lee, M. Kortylewski, M. Kujawski, H. Kay, W.D. Cress, R. Jove, and H. Yu Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells Mol. Cancer Res. 6 2008 1099 1105
311. Q. Xu, J. Briggs, S. Park, G. Niu, M. Kortylewski, S. Zhang, T. Gritsko, J. Turkson, H. Kay, G.L. Semenza, J.Q. Cheng, R. Jove, and H. Yu Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways Oncogene 24 2005 5552 5560
312. M.J. Gray, J. Zhang, L.M. Ellis, G.L. Semenza, D.B. Evans, S.S. Watowich, and G.E. Gallick HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas Oncogene 24 2005 3110 3120
313. Y.J. Surh, J.K. Kundu, and H.K. Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med. 74 2008 1526 1539
314. T.O. Khor, S. Yu, and A.N. Kong Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway Planta Med. 74 2008 1540 1547
315. J.K. Kundu, and Y.J. Surh Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis Pharm. Res. 27 2010 999 1013
316. W.O. Osburn, B. Karim, P.M. Dolan, G. Liu, M. Yamamoto, D.L. Huso, and T.W. Kensler Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment Int. J. Cancer 121 2007 1883 1891
317. W. Xu, C. Hellerbrand, U.A. Kohler, P. Bugnon, Y.W. Kan, S. Werner, and T.A. Beyer The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis Lab. Invest. 88 2008 1068 1078
318. Y.J. Li, H. Takizawa, A. Azuma, T. Kohyama, Y. Yamauchi, S. Takahashi, M. Yamamoto, T. Kawada, S. Kudoh, and I. Sugawara Disruption of Nrf2 enhances susceptibility to airway inflammatory responses induced by low-dose diesel exhaust particles in mice Clin. Immunol. 128 2008 366 373
319. T. Jiang, N. Chen, F. Zhao, X.J. Wang, B. Kong, W. Zheng, and D.D. Zhang High levels of Nrf2 determine chemoresistance in type II endometrial cancer Cancer Res. 70 2010 5486 5496
320. X.J. Wang, Z. Sun, N.F. Villeneuve, S. Zhang, F. Zhao, Y. Li, W. Chen, X. Yi, W. Zheng, G.T. Wondrak, P.K. Wong, and D.D. Zhang Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Carcinogenesis 29 2008 1235 1243
321. A. Arlt, I. Bauer, C. Schafmayer, J. Tepel, S.S. Muerkoster, M. Brosch, C. Roder, H. Kalthoff, J. Hampe, M.P. Moyer, U.R. Folsch, and H. Schafer Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) Oncogene 28 2009 3983 3996
322. S. Sebens, I. Bauer, C. Geismann, E. Grage-Griebenow, S. Ehlers, M.L. Kruse, A. Arlt, and H. Schafer Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection J. Biol. Chem. 286 2011 40911 40921
323. S. Saccani, S. Pantano, and G. Natoli p38-dependent marking of inflammatory genes for increased NF-κB recruitment Nat. Immunol. 3 2002 69 75
324. Y. Yamamoto, U.N. Verma, S. Prajapati, Y.T. Kwak, and R.B. Gaynor Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression Nature 423 2003 655 659
325. F.M. Moodie, J.A. Marwick, C.S. Anderson, P. Szulakowski, S.K. Biswas, M.R. Bauter, I. Kilty, and I. Rahman Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells FASEB J. 18 2004 1897 1899
326. D. Cao, P.A. Bromberg, and J.M. Samet COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1 Am. J. Respir. Cell Mol. Biol. 37 2007 232 239
327. R.A. Edwards, M. Witherspoon, K. Wang, K. Afrasiabi, T. Pham, L. Birnbaumer, and S.M. Lipkin Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer Cancer Res. 69 2009 6423 6429
328. S. Wellmann, M. Bettkober, A. Zelmer, K. Seeger, M. Faigle, H.K. Eltzschig, and C. Buhrer Hypoxia upregulates the histone demethylase JMJD1A via HIF-1 Biochem. Biophys. Res. Commun. 372 2008 892 897
329. J.A. Watson, C.J. Watson, A.M. McCrohan, K. Woodfine, M. Tosetto, J. McDaid, E. Gallagher, D. Betts, J. Baugh, J. O'Sullivan, A. Murrell, R.W. Watson, and A. McCann Generation of an epigenetic signature by chronic hypoxia in prostate cells Hum. Mol. Genet. 18 2009 3594 3604
330. I. Tischoff, C. Wittekind, and A. Tannapfel Role of epigenetic alterations in cholangiocarcinoma J. Hepatobiliary Pancreat. Surg. 13 2006 274 279
331. V. Valinluck, and L.C. Sowers Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers Cancer Res. 67 2007 5583 5586
332. Z. Herceg Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis 22 2007 91 103
333. K. Murao, Y. Kubo, N. Ohtani, E. Hara, and S. Arase Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways Br. J. Dermatol. 155 2006 999 1005
334. T. Ushiku, J.M. Chong, H. Uozaki, R. Hino, M.S. Chang, M. Sudo, B.R. Rani, K. Sakuma, H. Nagai, and M. Fukayama p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma Int. J. Cancer 120 2007 60 66
335. J.P. Issa, N. Ahuja, M. Toyota, M.P. Bronner, and T.A. Brentnall Accelerated age-related CpG island methylation in ulcerative colitis Cancer Res. 61 2001 3573 3577
336. K. Schulmann, A. Sterian, A. Berki, J. Yin, F. Sato, Y. Xu, A. Olaru, S. Wang, Y. Mori, E. Deacu, J. Hamilton, T. Kan, M.J. Krasna, D.G. Beer, M.S. Pepe, J.M. Abraham, Z. Feng, W. Schmiegel, B.D. Greenwald, and S.J. Meltzer Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk Oncogene 24 2005 4138 4148
337. T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, M. Iguchi, K. Arii, A. Kaneda, T. Tsukamoto, M. Tatematsu, G. Tamura, D. Saito, T. Sugimura, M. Ichinose, and T. Ushijima High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk Clin. Cancer Res. 12 2006 989 995
338. A.O. Chan, S.K. Lam, B.C. Wong, W.M. Wong, M.F. Yuen, Y.H. Yeung, W.M. Hui, A. Rashid, and Y.L. Kwong Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer Gut 52 2003 502 506
339. M.A. Hahn, T. Hahn, D.H. Lee, R.S. Esworthy, B.W. Kim, A.D. Riggs, F.F. Chu, and G.P. Pfeifer Methylation of polycomb target genes in intestinal cancer is mediated by inflammation Cancer Res. 68 2008 10280 10289
340. D.R. Hodge, B. Peng, J.C. Cherry, E.M. Hurt, S.D. Fox, J.A. Kelley, D.J. Munroe, and W.L. Farrar Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation Cancer Res. 65 2005 4673 4682
341. Z. Wang, Y. Li, and F.H. Sarkar Signaling mechanism(s) of reactive oxygen species in epithelial-mesenchymal transition reminiscent of cancer stem cells in tumor progression Curr. Stem Cell Res. Ther. 5 2010 74 80
342. M.A. St John, M. Dohadwala, J. Luo, G. Wang, G. Lee, H. Shih, E. Heinrich, K. Krysan, T. Walser, S. Hazra, L. Zhu, C. Lai, E. Abemayor, M. Fishbein, D.A. Elashoff, S. Sharma, and S.M. Dubinett Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma Clin. Cancer Res. 15 2009 6018 6027
343. M. Dohadwala, G. Wang, E. Heinrich, J. Luo, O. Lau, H. Shih, Q. Munaim, G. Lee, L. Hong, C. Lai, E. Abemayor, M.C. Fishbein, D.A. Elashoff, S.M. Dubinett, and M.A. St John The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC Otolaryngol. Head Neck Surg. 142 2010 753 759
344. R. Dong, Q. Wang, X.L. He, Y.K. Chu, J.G. Lu, and Q.J. Ma Role of nuclear factor κB and reactive oxygen species in the tumor necrosis factor-α-induced epithelial-mesenchymal transition of MCF-7 cells Braz. J. Med. Biol. Res. 40 2007 1071 1078
345. Y. Wu, J. Deng, P.G. Rychahou, S. Qiu, B.M. Evers, and B.P. Zhou Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion Cancer Cell 15 2009 416 428
346. F. Du, Y. Nakamura, T.L. Tan, P. Lee, R. Lee, B. Yu, and C. Jamora Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conducive to tumor formation Cancer Res. 70 2010 10080 10089
347. A. Giannakakis, G. Coukos, A. Hatzigeorgiou, R. Sandaltzopoulos, and L. Zhang miRNA genetic alterations in human cancers Expert Opin. Biol. Ther. 7 2007 1375 1386
348. J.R. O'Rourke, M.S. Swanson, and B.D. Harfe MicroRNAs in mammalian development and tumorigenesis Birth Defects Res. C Embryo Today 78 2006 172 179
349. H. Osada, and T. Takahashi MicroRNAs in biological processes and carcinogenesis Carcinogenesis 28 2007 2 12
350. F. Meng, R. Henson, H. Wehbe-Janek, H. Smith, Y. Ueno, and T. Patel The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes J. Biol. Chem. 282 2007 8256 8264
351. F. Meng, H. Wehbe-Janek, R. Henson, H. Smith, and T. Patel Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes Oncogene 27 2008 378 386
352. C. Braconi, N. Huang, and T. Patel MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes Hepatology 51 2010 881 890
353. D. Iliopoulos, S.A. Jaeger, H.A. Hirsch, M.L. Bulyk, and K. Struhl STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer Mol. Cell 39 2010 493 506
354. E. Tili, J.J. Michaille, D. Wernicke, H. Alder, S. Costinean, S. Volinia, and C.M. Croce Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer Proc. Natl. Acad. Sci. U. S. A. 108 2011 4908 4913
355. S. Jiang, H.W. Zhang, M.H. Lu, X.H. He, Y. Li, H. Gu, M.F. Liu, and E.D. Wang MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Res. 70 2010 3119 3127
356. I.M. Pedersen, D. Otero, E. Kao, A.V. Miletic, C. Hother, E. Ralfkiaer, R.C. Rickert, K. Gronbaek, and M. David Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas EMBO Mol. Med. 1 2009 288 295
357. T. Takagi, Y. Naito, K. Mizushima, I. Hirata, N. Yagi, N. Tomatsuri, T. Ando, Y. Oyamada, Y. Isozaki, H. Hongo, K. Uchiyama, O. Handa, S. Kokura, H. Ichikawa, and T. Yoshikawa Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis J. Gastroenterol. Hepatol. 25 Suppl. 1 2010 S129 S133
358. M. He, Z. Xu, T. Ding, D.M. Kuang, and L. Zheng MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPβ Cell. Mol. Immunol. 6 2009 343 352
359. O. Haworth, M. Cernadas, R. Yang, C.N. Serhan, and B.D. Levy Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation Nat. Immunol. 9 2008 873 879
360. T. Ishida, M. Yoshida, M. Arita, Y. Nishitani, S. Nishiumi, A. Masuda, S. Mizuno, T. Takagawa, Y. Morita, H. Kutsumi, H. Inokuchi, C.N. Serhan, R.S. Blumberg, and T. Azuma Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis Inflamm. Bowel Dis. 16 2010 87 95
361. O.A. Haabeth, K.B. Lorvik, C. Hammarstrom, I.M. Donaldson, G. Haraldsen, B. Bogen, and A. Corthay Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer Nat. Commun. 2 2011 240
362. M. Dean Cancer stem cells: redefining the paradigm of cancer treatment strategies Mol. Interv. 6 2006 140 148